These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1398651)

  • 21. Failure to detect prostate cancer in the PSA era: comments on N Engl J Med 2003; 349: 215-224 and N Engl J Med 2003; 349: 335-342.
    Platz EA; De Marzo AM; Giovannucci E
    Cancer Causes Control; 2004 Feb; 15(1):91-4. PubMed ID: 14970739
    [No Abstract]   [Full Text] [Related]  

  • 22. Another application of PAX8: to confirm the presence of seminal vesicle epithelium in prostate needle biopsies.
    Ortiz-Rey JA; Juaneda-Benavides L; Peteiro-Cancelo Á; de María CG; Tejado BS; Tardío-Baigés A
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):161-2. PubMed ID: 25153494
    [No Abstract]   [Full Text] [Related]  

  • 23. Ultrasound versus digitally directed prostatic needle biopsy.
    Liddell HT; McDougal WS; Burks DD; Fleischer AC
    J Urol; 1986 Apr; 135(4):716-8. PubMed ID: 2421015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinoma of prostate. Local extension following perineal needle biopsy.
    Desai SG; Woodruff LM
    Urology; 1974 Jan; 3(1):87-8. PubMed ID: 4812904
    [No Abstract]   [Full Text] [Related]  

  • 25. Histologic and cytologic diagnosis of prostatic carcinoma by ultrasound-guided needle biopsy.
    Soiderer MH
    Prog Clin Biol Res; 1987; 237():125-31. PubMed ID: 3317423
    [No Abstract]   [Full Text] [Related]  

  • 26. Supraclavicular lymphadenopathy and carcinoma of the prostate: aspiration cytology in the diagnosis of both.
    Fletcher DR; Orell SR
    Med J Aust; 1974 Dec; 2(24):866-9. PubMed ID: 4453257
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prostate cancer histoseminar: Update of the 2016 WHO classification - case No. 8: Acinar prostatic adenocarcinoma, Gleason score 6 (3+3)].
    Ferlicot S
    Ann Pathol; 2017 Jun; 37(3):259-263. PubMed ID: 28522121
    [No Abstract]   [Full Text] [Related]  

  • 28. A simple way to improve immunoreactivity of prostate needle biopsies fixed in Bouin's solution to AMACR.
    Ortiz-Rey JA; San Miguel-Fraile P; Gómez de María C; Huri de Lama S; Rodríguez Sánchez MC
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):280-2. PubMed ID: 22935828
    [No Abstract]   [Full Text] [Related]  

  • 29. Aspiration biopsy of the prostate: a community hospital's experience.
    Niejadlik DC; Dwyer RD; Rousseau D
    Conn Med; 1990 May; 54(5):243-5. PubMed ID: 2369823
    [No Abstract]   [Full Text] [Related]  

  • 30. Transrectal fine-needle aspiration biopsy of prostatic carcinoma.
    Willems JS
    Acta Urol Belg; 1983; 51(1):43-55. PubMed ID: 6190389
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostatic adenocarcinoma metastatic to axillary lymph node diagnosed by fine-needle aspiration biopsy.
    Collins GR; Lopez Y; Abreo F
    Diagn Cytopathol; 2012 Aug; 40(8):751-3. PubMed ID: 21538951
    [No Abstract]   [Full Text] [Related]  

  • 32. Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density.
    Allan RW; Sanderson H; Epstein JI
    J Urol; 2003 Aug; 170(2 Pt 1):370-2. PubMed ID: 12853777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic yield of touch imprint cytology of prostate core needle biopsies.
    Mannweiler S; Pummer K; Auprich M; Galle G; Méhes G; Ratschek M; Tsybrovskyy O; Moinfar F
    Pathol Oncol Res; 2009 Mar; 15(1):97-101. PubMed ID: 18958585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
    Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
    Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of transrectal aspiration biopsy in the diagnosis of prostatic cancer.
    Chodak GW; Steinberg GD; Bibbo M; Wied G; Straus FS; Vogelzang NJ; Schoenberg HW
    J Urol; 1986 Feb; 135(2):299-302. PubMed ID: 3944865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Needle biopsy of the prostate.
    Hoskins JH; Mellinger GT
    GP; 1966 Aug; 34(2):88-92. PubMed ID: 5946418
    [No Abstract]   [Full Text] [Related]  

  • 37. Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy.
    Epstein JI
    Hum Pathol; 1995 Feb; 26(2):223-9. PubMed ID: 7860053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In the diagnosis of limited prostate cancer, is observer variability an important consideration when compared with variability of patient outcome?
    Dalton L
    Am J Surg Pathol; 2010 Jul; 34(7):1071-2; author reply 1072. PubMed ID: 20495442
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cytological diagnosis of prostatic cancer].
    Proskura NS
    Vopr Onkol; 1979; 25(6):115-7. PubMed ID: 88808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of prostate adenocarcinoma using transurethral resection of the prostate after multiple negative transrectal biopsies and persistently elevated prostate-specific antigen level.
    Vanasupa BP; Miller TA; Schwartz BF
    Urology; 2000 Dec; 56(6):1056. PubMed ID: 11113765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.